Efficacy and tolerability of rituximab with or without PEGylated interferon alfa-2b plus ribavirin in severe hepatitis C virus-related vasculitis: a long-term followup study of thirty-two patients (Q43874759)
Jump to navigation
Jump to search
scientific article published in August 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and tolerability of rituximab with or without PEGylated interferon alfa-2b plus ribavirin in severe hepatitis C virus-related vasculitis: a long-term followup study of thirty-two patients |
scientific article published in August 2009 |
Statements
1 reference
Efficacy and tolerability of rituximab with or without PEGylated interferon alfa-2b plus ribavirin in severe hepatitis C virus-related vasculitis: a long-term followup study of thirty-two patients (English)
1 reference
1 reference
1 reference
Benjamin Terrier
1 reference
David Saadoun
1 reference
Damien Sène
1 reference
Jérémie Sellam
1 reference
Laurent Pérard
1 reference
Brigitte Coppéré
1 reference
Alexandre Karras
1 reference
François Blanc
1 reference
Matthias Buchler
1 reference
Emmanuelle Plaisier
1 reference
Pascale Ghillani
1 reference
1 August 2009
1 reference
1 reference
60
1 reference
8
1 reference
2531-2540
1 reference
Identifiers
1 reference
1 reference